Skip to content

Celcuity CELC Cash ratio

Cash ratio at other companies

Eli Lilly logo
Eli LillyLLY
0.1×0.0×
Gilead Sciences logo
Gilead SciencesGILD
0.8×+0.2×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.1×-2.5×
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
6.9×+4.4×
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
4.2×+1.6×
Tango Therapeutics logo
Tango TherapeuticsTNGX
11.2×+9.5×

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Calculated from Celcuity’s reported figures.

Based on the most recent quarter.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's cash ratio?
Celcuity (CELC) reported cash ratio of 4.4× in Q1 2026.
How has Celcuity's cash ratio changed year-over-year?
Celcuity's cash ratio increased by 773.3% year-over-year, from 0.5× to 4.4×.
What is the long-term trend for Celcuity's cash ratio?
Over 5 years (2020 to 2025), Celcuity's cash ratio has grown at a -1.8% compound annual growth rate (CAGR), from 9.6× to 8.8×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.